Harvard scientists develop TxGNN, an AI model using zero-shot learning to identify new uses for existing drugs, potentially closing treatment gaps for rare diseases. (Read More)
AI Model TxGNN Utilizes Zero-Shot Learning to Repurpose Drugs for Rare Diseases
